Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of early vs delayed progression on clinical and economic outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first-line therapy: results from the IMPACT RCC claims data analysis.
Hutson TE, Liu FX, Dieyi C, Kim R, Krulewicz S, Kasturi V, Bhanegaonkar A. Hutson TE, et al. Among authors: bhanegaonkar a. J Manag Care Spec Pharm. 2021 Sep;27(9):1171-1181. doi: 10.18553/jmcp.2021.20569. Epub 2021 Jun 24. J Manag Care Spec Pharm. 2021. PMID: 34165322 Free PMC article.
Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR).
Doshi GK, Bhanegaonkar A, Kearney M, Bharmal M, Cislo P, Kim R, Boyd M, Aguilar KM, Phatak H. Doshi GK, et al. Among authors: bhanegaonkar a. Clinicoecon Outcomes Res. 2020 Nov 5;12:645-656. doi: 10.2147/CEOR.S264942. eCollection 2020. Clinicoecon Outcomes Res. 2020. PMID: 33192078 Free PMC article.
Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives.
Kongnakorn T, Bharmal M, Kearney M, Phatak H, Benedict A, Bhanegaonkar A, Galsky M. Kongnakorn T, et al. Among authors: bhanegaonkar a. Clinicoecon Outcomes Res. 2019 Nov 8;11:659-672. doi: 10.2147/CEOR.S215069. eCollection 2019. Clinicoecon Outcomes Res. 2019. PMID: 31807039 Free PMC article.
22 results